[go: up one dir, main page]

NO20013645D0 - Anvendelse av pyridazino[4,5-b]indol-1-acetamid-derivater for fremstilling av medisiner for behandling av sykdommer relatert tildysfunksjonen av perifere benzodiazepinreseptorer - Google Patents

Anvendelse av pyridazino[4,5-b]indol-1-acetamid-derivater for fremstilling av medisiner for behandling av sykdommer relatert tildysfunksjonen av perifere benzodiazepinreseptorer

Info

Publication number
NO20013645D0
NO20013645D0 NO20013645A NO20013645A NO20013645D0 NO 20013645 D0 NO20013645 D0 NO 20013645D0 NO 20013645 A NO20013645 A NO 20013645A NO 20013645 A NO20013645 A NO 20013645A NO 20013645 D0 NO20013645 D0 NO 20013645D0
Authority
NO
Norway
Prior art keywords
pyridazino
medications
indole
dysfunction
preparation
Prior art date
Application number
NO20013645A
Other languages
English (en)
Other versions
NO20013645L (no
NO321997B1 (no
Inventor
Badia Ferzaz
Jesus Benavides
Frank Marguet
Jacques Froissant
Benoit Marabout
Yannick Evanno
Mireille Sevrin
Philip Janiak
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO20013645D0 publication Critical patent/NO20013645D0/no
Publication of NO20013645L publication Critical patent/NO20013645L/no
Publication of NO321997B1 publication Critical patent/NO321997B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20013645A 1999-01-26 2001-07-24 Anvendelse av pyridazino[4,5-b]indol-1-acetamid-derivater for fremstilling av et medikament for forebygging og behandling av sykdommer og lidelser knyttet til dysfunksjonering av perifer-type benzodiazepinreseptorer NO321997B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9900806A FR2788696B1 (fr) 1999-01-26 1999-01-26 Utilisation de derives de pyridazino [4,5-b] indole-1-acetamide pour la preparation de medicaments destines aux maladies du systeme nerveux central
PCT/FR2000/000135 WO2000044384A1 (fr) 1999-01-26 2000-01-21 UTILISATION DE DERIVES DE PYRIDAZINO[4,5-b]INDOLE-1-ACETAMIDE POUR LA PREPARATION DE MEDICAMENTS DESTINES AUX MALADIES LIEES AU DYSFONCTIONNEMENT DES RECEPTEURS DE TYPE PERIPHERIQUE AUX BENZODIAZEPINES

Publications (3)

Publication Number Publication Date
NO20013645D0 true NO20013645D0 (no) 2001-07-24
NO20013645L NO20013645L (no) 2001-09-26
NO321997B1 NO321997B1 (no) 2006-07-31

Family

ID=9541212

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013645A NO321997B1 (no) 1999-01-26 2001-07-24 Anvendelse av pyridazino[4,5-b]indol-1-acetamid-derivater for fremstilling av et medikament for forebygging og behandling av sykdommer og lidelser knyttet til dysfunksjonering av perifer-type benzodiazepinreseptorer

Country Status (32)

Country Link
US (1) US6395729B1 (no)
EP (1) EP1148881B1 (no)
JP (1) JP4688295B2 (no)
KR (1) KR100694752B1 (no)
CN (1) CN100577167C (no)
AR (1) AR022413A1 (no)
AT (1) ATE335487T1 (no)
AU (1) AU764445B2 (no)
BG (1) BG65152B1 (no)
BR (1) BR0007718A (no)
CA (1) CA2360754C (no)
CO (1) CO5160242A1 (no)
CY (1) CY1106257T1 (no)
CZ (1) CZ294283B6 (no)
DE (1) DE60029929T2 (no)
DK (1) DK1148881T3 (no)
EE (1) EE04905B1 (no)
ES (1) ES2269097T3 (no)
FR (1) FR2788696B1 (no)
HK (1) HK1040905B (no)
HU (1) HU228670B1 (no)
IL (2) IL144181A0 (no)
NO (1) NO321997B1 (no)
NZ (1) NZ512981A (no)
PL (1) PL193420B1 (no)
PT (1) PT1148881E (no)
RU (1) RU2243764C2 (no)
SK (1) SK285707B6 (no)
TR (1) TR200102134T2 (no)
TW (1) TW541177B (no)
UA (1) UA70349C2 (no)
WO (1) WO2000044384A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9915940A (pt) * 1998-12-02 2001-09-11 Pfizer Prod Inc Métodos e composições para restaurar a estabilidade conformacional de uma proteìna da famìlia p53
FR2811897A1 (fr) * 2000-07-24 2002-01-25 Sanofi Synthelabo UTILISATION DE DERIVES DE PYRIDAZINO[4,5-b]INDOLE-1- ACETAMIDE POUR LA PREPARATION DE MEDICAMENTS DESTINES AU TRAITEMENT DES DYSFONCTIONNEMENTS DES RECEPTEURS DE TYPE PERIPHERIQUE AUX BENZODIAZEPINES
FR2838124B1 (fr) * 2002-04-03 2004-05-28 Sanofi Synthelabo Derives de 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-acetamide, leur preparation et leur application en therapeutique
FR2876715B1 (fr) 2004-10-19 2006-12-15 Profiles Du Ct Sa Embout de protection pour ecran de glissiere de securite routiere
GT200600005A (es) * 2005-01-12 2006-08-16 Un derivado de 2-(aminocarbonilo ciclico)-indolina y una composicion farmaceutica que lo contiene
CN101252914B (zh) * 2005-05-05 2013-03-27 塞诺菲-安万特美国有限责任公司 稳定的纳米粒制剂
EA014164B1 (ru) * 2005-08-29 2010-10-29 САНОФИ-АВЕНТИС Ю.Эс. ЭлЭлСи Новая кристаллическая форма производного пиридазино[4,5-в]индола
EP1926476B1 (en) * 2005-08-29 2013-04-10 Sanofi-Aventis U.S. LLC Amorphous solid dispersions of 7-chloro-n,n,5-trimethyl-4-oxo-3-phenyl-3,5,-dihydro-4h-pyridazino[4,5-b]indole-1-acetamide
CN1946120B (zh) * 2006-10-20 2010-05-12 华为技术有限公司 实现话单关联的方法及系统
FR2918563B1 (fr) 2007-07-12 2009-12-04 Oreal Composition photoprotectrice fluide aqueuse a base d'un polymere polyamide a terminaison amide tertiaire.
FR2931064B1 (fr) 2008-05-14 2010-08-13 Oreal Composition cosmetique contenant un derive de dibenzoylmethane et un derive de pyrrolidinone; procede de photostabilisation du derive de dibenzoylmethane
RU2011110241A (ru) * 2008-08-18 2012-09-27 САНОФИ-АВЕНТИС Ю.Эс. ЭлЭлСи (US) СПОСОБ ПОЛУЧЕНИЯ ПОЛИМОРФА 7-ХЛОР-N,N,5-ТРИМЕТИЛ-4-ОКСО-3-ФЕНИЛ-3,5-ДИГИДРО-4Н-ПИРИДАЗИНО[4,5-b]ИНДОЛ-1-АЦЕТАМИДА
GB0818738D0 (en) * 2008-10-13 2008-11-19 Ge Healthcare Ltd Imaging neuroflammation
FR2936706B1 (fr) 2008-10-08 2010-12-17 Oreal Composition cosmetique contenant un derive de dibenzoylmethane et un compose dithiolane ; procede de photostabilisation du derive de dibenzoylmethane
EP2181717A1 (en) * 2008-10-28 2010-05-05 Sanofi-Aventis Use of 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-B]indole-1-acetamide as a biomarker of peripheral benzodiazepine receptor levels
WO2011073576A2 (fr) 2009-12-18 2011-06-23 L'oreal Procede de coloration de la peau impliquant un compose apte a condenser in situ et un agent colorant de la peau
FR2960773B1 (fr) 2010-06-03 2015-12-11 Oreal Procedes de traitement cosmetique utilisant un revetement a base d'un polymere polyamide-polyether
WO2019113248A1 (en) * 2017-12-07 2019-06-13 The Regents Of The University Of California Anti-upar antibody-drug conjugates and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3121137A1 (de) * 1981-05-27 1982-12-16 Hoechst Ag, 6000 Frankfurt Neue pyridazino(4,5-b)indole, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen, zwischenprodukte und deren herstellung"
GB9411955D0 (en) * 1994-06-15 1994-08-03 Merck Sharp & Dohme Therapeutic agents
FR2754262B1 (fr) * 1996-10-08 1998-10-30 Synthelabo Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique
US6031120A (en) * 1997-07-29 2000-02-29 E. I. Du Pont De Nemours And Company Selective synthesis of organodiphosphite compounds
FR2766823B1 (fr) * 1997-07-30 1999-10-08 Synthelabo Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique
FR2788776B1 (fr) * 1999-01-26 2001-02-23 Synthelabo Derives de 4-oxo-3, 5-dihydro-4h-pyridazino [4,5-b] indole-1 -carboxamide, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
FR2788696A1 (fr) 2000-07-28
EE200100388A (et) 2002-12-16
BG65152B1 (bg) 2007-04-30
AU764445B2 (en) 2003-08-21
EE04905B1 (et) 2007-10-15
HU228670B1 (en) 2013-05-28
IL144181A0 (en) 2002-05-23
UA70349C2 (en) 2004-10-15
US6395729B1 (en) 2002-05-28
ES2269097T3 (es) 2007-04-01
EP1148881A1 (fr) 2001-10-31
KR20010089624A (ko) 2001-10-06
RU2243764C2 (ru) 2005-01-10
NO20013645L (no) 2001-09-26
SK285707B6 (sk) 2007-06-07
JP2002535370A (ja) 2002-10-22
CY1106257T1 (el) 2011-06-08
CO5160242A1 (es) 2002-05-30
TW541177B (en) 2003-07-11
AR022413A1 (es) 2002-09-04
PL193420B1 (pl) 2007-02-28
HUP0201280A3 (en) 2004-12-28
CN1344161A (zh) 2002-04-10
FR2788696B1 (fr) 2004-03-05
DE60029929D1 (de) 2006-09-21
BG105728A (en) 2002-02-28
WO2000044384A1 (fr) 2000-08-03
IL144181A (en) 2007-06-17
NZ512981A (en) 2002-10-25
JP4688295B2 (ja) 2011-05-25
NO321997B1 (no) 2006-07-31
PT1148881E (pt) 2006-12-29
CN100577167C (zh) 2010-01-06
KR100694752B1 (ko) 2007-03-14
HK1040905B (zh) 2007-02-23
DE60029929T2 (de) 2007-08-30
AU3057900A (en) 2000-08-18
PL349364A1 (en) 2002-07-15
BR0007718A (pt) 2001-11-13
CZ20012681A3 (cs) 2001-10-17
HUP0201280A2 (en) 2002-08-28
CA2360754C (en) 2008-07-08
ATE335487T1 (de) 2006-09-15
CA2360754A1 (en) 2000-08-03
TR200102134T2 (tr) 2003-03-21
DK1148881T3 (da) 2006-12-11
HK1040905A1 (en) 2002-06-28
EP1148881B1 (fr) 2006-08-09
CZ294283B6 (cs) 2004-11-10
SK10502001A3 (sk) 2002-01-07

Similar Documents

Publication Publication Date Title
NO20013645D0 (no) Anvendelse av pyridazino[4,5-b]indol-1-acetamid-derivater for fremstilling av medisiner for behandling av sykdommer relatert tildysfunksjonen av perifere benzodiazepinreseptorer
HUP0203437A3 (en) Use of resorcinol derivatives for producing pharmaceutical compositions for treatment of immune diseases
HUP0102300A3 (en) Use of diazepin derivatives for preparing medicines for treating diseases influenced by somatostatine receptor, and new compounds
EP0982030A3 (en) 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives as 5ht 1a ligands
HUP0303350A3 (en) Use of substituted imidazo[1,2-a]pyridine-, imidazo[1,2-a]pyrimidine and imidazo[1,2-a]pyrazine-3-yl-amine derivatives for producing nos-inhibiting pharmaceutical compositions
HUP0203142A3 (en) Benzodiazepine derivatives, process for preparation of the compounds, pharmaceutical compositions containing them and their use
DE69830503D1 (de) Tablette mit verlängerter wirkstoffabgabe zur behandlung der parkinsonkrankheit
HUP0202103A3 (en) 8-phenyl-6,9-dihydro-[1,2,4]triazolo[3,4-i]purin-5-one derivatives, their use, pharmaceutical compositions containing them, process for the preparation of the compounds and intermediates
PL373414A1 (en) 8-methoxy-(1,2,4)triazolo(1,5-a)pyridine derivatives and their use as adenosine receptor ligands
HUP0301167A3 (en) Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders, process for their preparation, pharmaceutical compositions containing them and their use
EE200100377A (et) Imidaso[1,5-a]-pürido[3,2-e]-pürasinoonide kasutamine arstimitena
NO974603D0 (no) Anvendelse av imidazo£1,2-a|pyridin-3-acetamidderivater for terapeutisk behandling av neuropsykiatriske syndromer assosiert med disfunksjon av de sentrale områder av de basale ganglia
AU6205700A (en) Azo amino acid derivatives for the treatment of neurological diseases
ZA983602B (en) Use of tetrahydropyridine derivatives for the preparation of drugs for the treatment of diseases which cause demyelination
HUP0002963A3 (en) Use of pyrazolo-[4,3-d] pyrimidinon derivatives for the production of pharmaceutical compositions for treating diseases of the eye field
DE69908608D1 (de) Derivate von Imidazo[1,2-a]pyridin zur Behandlung von gastrointestinalen Krankheiten
NZ515882A (en) Treatment of serotonin related disorders with 2,7-substituted octahydro-1H-pyrido[1,2-a]pyrazine derivatives
DE69808921D1 (de) 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOL-1-ACETAMID-DERIVATE, IHRE HERSTELLUNG UND THERAPEUTISCHE ANWENDUNG
AU8553898A (en) Use of 2,3-benzodiazepine derivatives for the preparation of pharmaceutical compositions to treat diseases connected with the endogenous opioid system
HUP0300569A3 (en) Pyrano[2,3-c]imidazo[-1,2-a]pyridine derivatives for the treatment of gastrointestinal disorders and pharmaceutical compositions containing the compounds
DE60002043D1 (de) 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b]indol-1-carboxamid-derivate, ihre herstellung und therapeutische verwendung
HUP0004193A3 (en) 9-(3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3'4':6,7]naphtho[2,3-d][1,3]dioxol-6-(5ah)-one compounds, process for their preparation, pharmaceutical compositions containing them and the used intermediates
LV12188A (lv) 1,4-Dihidro-1,4-diokso-1H-naftalina triciklisku atvasinajumu pielietojums jaunu savienojumu iegusanai un to izmantosana terapija
NO20001894L (no) Anvendelse av TNF-antagonister som medikamenter for behandling av septiske sykdommer
AU6076000A (en) Cyclic amine derivatives for the treatment of neurological diseases

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees